Scpharmaceuticals Inc (SCPH)

4.600
-0.200(-4.17%)
  • Volume:
    74,633
  • Day's Range:
    4.420 - 4.900
  • 52 wk Range:
    3.480 - 7.280

SCPH Overview

Prev. Close
4.8
Day's Range
4.42-4.9
Revenue
-
Open
4.84
52 wk Range
3.48-7.28
EPS
-1.28
Volume
74,633
Market Cap
122.35M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
75,139
P/E Ratio
-
Beta
0.39
1-Year Change
-12.41%
Shares Outstanding
27,371,488
Next Earnings Date
Aug 10, 2022
What is your sentiment on Scpharmaceuticals?
or
Market is currently closed. Voting is open during market hours.

Scpharmaceuticals Inc Analysis

Scpharmaceuticals Inc Company Profile

Scpharmaceuticals Inc Company Profile

Employees
27

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company’s lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellSellStrong Sell
Technical IndicatorsStrong SellStrong SellSellBuyStrong Sell
SummaryStrong SellStrong SellStrong SellNeutralStrong Sell